Growth Metrics

Palisade Bio (PALI) Interest Coverage Ratio Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 15.31%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -76.51%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -303.06%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - 18.06%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -26.72%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1,150.63%
10 Palisade Bio 439.25 Mn 309.68 Mn - -365.28%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -365.28%
Dec 31, 2025 -342.68%
Sep 30, 2025 2.41%
Jun 30, 2025 32.49%
Mar 31, 2025 37.11%
Dec 31, 2024 -42.97%
Sep 30, 2024 -26.80%
Jun 30, 2024 -75.02%
Dec 31, 2023 38.53%
Sep 30, 2023 57.19%
Jun 30, 2023 -68.39%
Dec 31, 2022 -59.26%
Sep 30, 2022 -851.08%
Jun 30, 2022 -1,324.10%
Mar 31, 2022 -340,348.72%
Dec 31, 2021 -4,764.67%
Sep 30, 2021 -78.85%
Jun 30, 2021 77.05%
Mar 31, 2021 99.85%
Dec 31, 2020 96.52%
Sep 30, 2020 94.16%
Jun 30, 2020 94.22%
Mar 31, 2020 36.63%
Dec 31, 2019 7.54%
Sep 30, 2019 20.13%
Jun 30, 2019 -44.40%
Mar 31, 2019 0.45%
Dec 31, 2018 26.92%
Sep 30, 2018 25.70%
Jun 30, 2018 -877.05%
Mar 31, 2018 -3,910.62%
Dec 31, 2017 -2,290.56%
Sep 30, 2017 -9,050.96%
Jun 30, 2017 -2,155.17%
Mar 31, 2017 -89.14%
Dec 31, 2016 -197.25%
Sep 30, 2016 -82.63%
Jun 30, 2016 -9.31%
Mar 31, 2016 -58.64%
Dec 31, 2015 8.46%
Sep 30, 2015 1.41%
Jun 30, 2015 -23.21%
Mar 31, 2015 15.02%
Dec 31, 2014 -79.36%
Sep 30, 2014 -40.30%
Jun 30, 2014 -19.89%
Mar 31, 2014 80.04%
Dec 31, 2013 99.80%
Sep 30, 2013 99.90%
Jun 30, 2013 99.81%
Mar 31, 2013 97.92%
Dec 31, 2012 3.98%
Dec 31, 2011 -172,370.55%